Status:
RECRUITING
A Study Of MCG In Cardiac Amyloidosis
Lead Sponsor:
Mayo Clinic
Conditions:
Amyloidosis
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of this observational study is to evaluate the utility of magnetocardiography (MCG) in diagnosing and monitoring disease progression in patients with amyloidosis, and to assess i...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Age ≥ 18 years on the date of consent
- Ability for participant to comply with study requirements
- Written informed consent
- Exclusion Criteria
- Pregnant or breastfeeding
- Having an active atrial fibrillation episode as seen on most current 12-lead ECG
- Active thoracic metal implants (including pacemaker, insertable cardiac monitor, or internal defibrillator).
- External electrical pads or devices (e.g. Pacer pads, ECG electrodes, heart rate patch), that must remain on patient's chest during MCG scan
- Inability to lie down in a supine/inclined position and stay still on the examination bed
- Clinical conditions that in the opinion of the Investigator would compromise the safety of the patient or ability to complete the protocol
Exclusion
Key Trial Info
Start Date :
December 3 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT07218705
Start Date
December 3 2025
End Date
November 1 2027
Last Update
December 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905